$GEVA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in SYNAGEVA BIOPHARMA CORP. Get notifications about new insider transactions in SYNAGEVA BIOPHARMA CORP for free.

Page:   < prev 1 2 3 4 5 6 7 8 ... 9 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorOption ExerciseA40.3215,000604,80015,000
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9521,69520,61041,496
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.959,9109,41563,191
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.4921,6951,073,6861,03122.7 K to 1 K (-95.46 %)
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9521,69520,61022,7261 K to 22.7 K (+2,104.27 %)
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS50.119,910496,5901,03110.9 K to 1 K (-90.58 %)
Apr 09 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.959,9109,41510,9411 K to 10.9 K (+961.20 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9521,93120,83473,101
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.957,0006,65095,032
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.959,4648,99131,794
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS51.641,20061,9681,0312.2 K to 1 K (-53.79 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS50.722,151109,0992,2314.4 K to 2.2 K (-49.09 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS50.1218,580931,2484,38223 K to 4.4 K (-80.92 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9521,93120,83422,9621 K to 23 K (+2,127.16 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS54.4440021,7771,0311.4 K to 1 K (-27.95 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS53.371,50080,0601,4312.9 K to 1.4 K (-51.18 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS52.554,358229,0172,9317.3 K to 2.9 K (-59.79 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS51.0910,206521,3747,28917.5 K to 7.3 K (-58.34 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.957,0006,65017,49510.5 K to 17.5 K (+66.70 %)
Apr 05 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.959,4648,99110,4951 K to 10.5 K (+917.94 %)
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...Option ExerciseM0.953,0912,9361,034
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...Option ExerciseM0.951,3251,2591,926
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...SellS54.9261933,9950619 to 0 (-100.00 %)
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...SellS54.213,797205,8356194.4 K to 619 (-85.98 %)
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...BuyM0.953,0912,9364,4161.3 K to 4.4 K (+233.28 %)
Apr 03 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP,Medical&Regulat ...BuyM0.951,3251,2591,3250 to 1.3 K
Mar 06 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...Option ExerciseM0.954,4174,1963,251
Mar 06 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...SellS51.351,71387,96301.7 K to 0 (-100.00 %)
Mar 06 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...SellS50.392,704136,2551,7134.4 K to 1.7 K (-61.22 %)
Mar 06 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...BuyM0.954,4174,1964,4170 to 4.4 K
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9545,39243,12241,258
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.955,9545,656102,032
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9518,65417,72186,650
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.0245,3922,225,1161,03146.4 K to 1 K (-97.78 %)
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9545,39243,12246,4231 K to 46.4 K (+4,402.72 %)
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.605,954295,3181,0317 K to 1 K (-85.24 %)
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.4918,654923,1866,98525.6 K to 7 K (-72.76 %)
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.955,9545,65625,63919.7 K to 25.6 K (+30.25 %)
Feb 22 2013GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9518,65417,72119,6851 K to 19.7 K (+1,809.31 %)
Feb 05 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...Option ExerciseM0.954,4174,1967,668
Feb 05 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...SellS48.022,660127,73302.7 K to 0 (-100.00 %)
Feb 05 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...SellS47.331,75783,1592,6604.4 K to 2.7 K (-39.78 %)
Feb 05 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...BuyM0.954,4174,1964,4170 to 4.4 K
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.959,4478,97538,964
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.089,447473,10615,03524.5 K to 15 K (-38.59 %)
Jan 23 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.959,4478,97524,48215 K to 24.5 K (+62.83 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9520019048,411
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9535333548,611
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.0020010,00015,03515.2 K to 15 K (-1.31 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9520019015,23515 K to 15.2 K (+1.33 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.075,353268,02515,03520.4 K to 15 K (-26.26 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9535333520,38820 K to 20.4 K (+1.76 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.709,92716,87692,659
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS49.129,927487,61409.9 K to 0 (-100.00 %)
Jan 18 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.709,92716,8769,9270 to 9.9 K
Jan 15 2013GEVASYNAGEVA BIOPHARMA ...TISCH THOMAS JDirectorBuyP47.5321,039999,984373,560352.5 K to 373.6 K (+5.97 %)
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP47.5320,099955,305176,920156.8 K to 176.9 K (+12.82 %)
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP47.53839,62139,907,1866,782,2155.9 M to 6.8 M (+14.13 %)
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER JULIANDirectorBuyP47.5320,099955,305176,920156.8 K to 176.9 K (+12.82 %)
Jan 08 2013GEVASYNAGEVA BIOPHARMA ...BAKER JULIANDirectorBuyP47.53839,62139,907,1866,782,2155.9 M to 6.8 M (+14.13 %)
Jan 04 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...Option ExerciseM0.954,4174,19612,085
Jan 04 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...SellS47.524,417209,89604.4 K to 0 (-100.00 %)
Jan 04 2013GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...BuyM0.954,4174,1964,4170 to 4.4 K
Dec 21 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...Option ExerciseM0.954,0003,8001,877
Dec 21 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS46.071,60573,94201.6 K to 0 (-100.00 %)
Dec 21 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS45.832,395109,7631,6054 K to 1.6 K (-59.87 %)
Dec 21 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...BuyM0.954,0003,8004,0000 to 4 K
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9532,31930,703105,304
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9513,28112,617137,623
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9514,40013,680150,904
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS47.531,60076,0481,0312.6 K to 1 K (-60.81 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS47.0323,7151,115,3162,63126.3 K to 2.6 K (-90.01 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS45.977,004321,97426,34633.4 K to 26.3 K (-21.00 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9532,31930,70333,3501 K to 33.4 K (+3,134.72 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS45.3013,281601,6291,03114.3 K to 1 K (-92.80 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9513,28112,61714,3121 K to 14.3 K (+1,288.17 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS47.072,701127,1361,0313.7 K to 1 K (-72.37 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS45.873,300151,3713,7327 K to 3.7 K (-46.93 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS45.128,399378,9637,03215.4 K to 7 K (-54.43 %)
Dec 17 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9514,40013,68015,4311 K to 15.4 K (+1,396.70 %)
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9530,00028,500200,304
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.955,0004,750230,304
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.4230,0001,482,4921,03131 K to 1 K (-96.68 %)
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9530,00028,50031,0311 K to 31 K (+2,909.80 %)
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS48.875,000244,3261,0316 K to 1 K (-82.90 %)
Dec 04 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.955,0004,7506,0311 K to 6 K (+484.97 %)
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9512,00011,400165,304
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9523,00021,850177,304
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS48.1012,000577,2551,03113 K to 1 K (-92.09 %)
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9512,00011,40013,0311 K to 13 K (+1,163.92 %)
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.3423,0001,134,8501,03124 K to 1 K (-95.71 %)
Dec 06 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9523,00021,85024,0311 K to 24 K (+2,230.84 %)
Oct 18 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.709,92716,876102,586
Oct 18 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS51.1790046,0530900 to 0 (-100.00 %)
Oct 18 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS50.581,90096,1029002.8 K to 900 (-67.86 %)
Oct 18 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS49.887,127355,4952,8009.9 K to 2.8 K (-71.79 %)
Oct 18 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.709,92716,8769,9270 to 9.9 K
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...Option ExerciseM0.952,0001,900820
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...Option ExerciseM1.702,0003,4004,188
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS49.672,00099,34002 K to 0 (-100.00 %)
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS49.642,00099,2802,0004 K to 2 K (-50.00 %)
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...BuyM0.952,0001,9004,0002 K to 4 K (+100.00 %)
Oct 19 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...BuyM1.702,0003,4002,0000 to 2 K
Oct 09 2012GEVASYNAGEVA BIOPHARMA ...Williams GlenSVP, Technical Oper ...Option ExerciseA57.5640,0002,302,40040,000
Sep 06 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...Option ExerciseM0.951,0009505,877
Sep 06 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS49.5230014,8560300 to 0 (-100.00 %)
Sep 06 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...SellS48.9270034,2443001,000 to 300 (-70.00 %)
Sep 06 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...BuyM0.951,0009501,0000 to 1,000
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9554,81352,072235,304
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseM0.9515,18714,428290,117
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.3654,8132,705,3721,03155.8 K to 1 K (-98.15 %)
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9554,81352,07255,8441 K to 55.8 K (+5,316.49 %)
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOSellS49.8815,187757,5181,03116.2 K to 1 K (-93.64 %)
Sep 05 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOBuyM0.9515,18714,42816,2181 K to 16.2 K (+1,473.04 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.956,4006,08048,964
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.951,1001,04555,364
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.236,400321,50120,03526.4 K to 20 K (-24.21 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.956,4006,08026,43520 K to 26.4 K (+31.94 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.001,10055,00020,03521.1 K to 20 K (-5.20 %)
Jul 30 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.951,1001,04521,13520 K to 21.1 K (+5.49 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.9560057056,464
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseM0.951,9001,80557,064
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.0060030,00020,03520.6 K to 20 K (-2.91 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.9560057020,63520 K to 20.6 K (+2.99 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...SellS50.001,90095,00020,03521.9 K to 20 K (-8.66 %)
Jul 23 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...BuyM0.951,9001,80521,93520 K to 21.9 K (+9.48 %)
Jul 20 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.706,61811,251112,513
Jul 20 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS48.826,618323,09106.6 K to 0 (-100.00 %)
Jul 20 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.706,61811,2516,6180 to 6.6 K
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...TISCH THOMAS JDirectorBuyP41.2036,5001,503,800352,521316 K to 352.5 K (+11.55 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...TISCH THOMAS JDirectorBuyP41.2036,5001,503,800378,435341.9 K to 378.4 K (+10.67 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER JULIANDirectorBuyP41.2021,082868,578156,821135.7 K to 156.8 K (+15.53 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER JULIANDirectorBuyP41.20864,91835,634,6225,942,5945.1 M to 5.9 M (+17.03 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP41.2021,082868,578156,821135.7 K to 156.8 K (+15.53 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...BAKER FELIXDirectorBuyP41.20864,91835,634,6225,942,5945.1 M to 5.9 M (+17.03 %)
Jul 13 2012GEVASYNAGEVA BIOPHARMA ...TISCH DANIEL R10% OwnerSellS46.7529,2001,365,100186,357215.6 K to 186.4 K (-13.55 %)
Jul 12 2012GEVASYNAGEVA BIOPHARMA ...TISCH DANIEL R10% OwnerSellS45.7310,000457,250215,557225.6 K to 215.6 K (-4.43 %)
Jul 11 2012GEVASYNAGEVA BIOPHARMA ...TISCH DANIEL R10% OwnerSellS45.2310,000452,250225,557235.6 K to 225.6 K (-4.25 %)
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Patel Sanj KPresident & CEOOption ExerciseA40.74148,0006,029,520148,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...WIRTH PETEROption ExerciseA40.7415,000611,10015,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Goldberg Mark AlanSVP, Product Develo ...Option ExerciseA40.7445,0001,833,30045,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Heberlig ChrisVice President, Fin ...Option ExerciseA40.7415,000611,10015,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseA40.7445,0001,833,30045,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Quinn AnthonySVP, Chief Medical ...Option ExerciseA40.7445,0001,833,30045,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Quart Barry DOption ExerciseA40.747,500305,5507,500
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...TISCH THOMAS JOption ExerciseA40.7415,000611,10015,000
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...Malley ThomasOption ExerciseA40.747,500305,5507,500
Jun 29 2012GEVASYNAGEVA BIOPHARMA ...DAVIS STEPHENOption ExerciseA40.747,500305,5507,500

Page:   < prev 1 2 3 4 5 6 7 8 ... 9 next >

Contact us | Follow us on Twitter